Rivia.AI enables your prospects to experience your product and understand its value without any friction. Our no-code demo creation platform enables sales and marketing teams to create interactive product demos within minutes. We are backed by YC and empower hundreds of teams to create demos that convert.
Location: Switzerland
Employees: 1-10
Total raised: $125K
Founded date: 2021
Investors 1
| Date | Name | Website |
| - | Y Combinat... | ycombinato... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 30.08.2021 | Pre-Seed | $125K | - |
Mentions in press and media 7
| Date | Title | Description |
| 19.03.2026 | Rivia Secures $15M to Propel AI-Powered Clinical Trials into New Era | Zurich-based Rivia secured $15 million in Series A funding. This investment propels its AI-driven platform. Rivia tackles clinical trial complexity. Its agentic data engine unifies vast data. It streamlines operations. The company aims to c... |
| 19.03.2026 | Rivia: $15 Million Series A Raised By Clinical Trial Data Infrastructure Company | Rivia, a Zurich-based software development company focused on AI-driven clinical trial data infrastructure, has raised an oversubscribed $15 million Series A funding round, according to an announcement shared on the company’s LinkedIn page.... |
| 18.03.2026 | Rivia Raises $15M in Series A Funding | Rivia, a Zurich, Switzerland-based provider of a clinical trial data engine and AI platform, raised $15m in Series A funding. The round was led by Earlybird, with participation from Defiant, Speedinvest, Amino Collective, and Nina Capital. ... |
| 18.03.2026 | Rivia raises USD 15M Series A to bring clinical trials into the agentic AI era | Clinical trials are increasingly complex, with data volumes growing over 400% in the past decade. Yet many biotech and pharma operators still rely on fragmented spreadsheets and outdated systems, spending thousands of human hours on repetit... |
| 18.03.2026 | Zurich-based Rivia raises €13 million to power complex clinical trials with its agentic data engine | Rivia, a Zurich-based startup specialising in AI-driven analytics and clinical trial data infrastructure for BioTechs, today announced a €13 million ($15 million) Series A to accelerate team growth, scale agentic product development, and ex... |
| 01.09.2021 | Here are all the companies from Day 2 of Y Combinator’s Summer 2021 Demo Day | Welcome back to TechCrunch’s continuing coverage of Y Combinator’s Summer 2021 Demo Day! This is Day Two. If you haven’t caught up yet on what happened during the first day, you can read our recap of all the presenting companies here, our f... |
| - | Here’s The List of 31 Indian Startups From Y Combinator’s Summer’21 Demo Day | It was another great moment for the Indian startup ecosystem as 31 startups from the country made it to Y Combinator’s summer batch of 2021. For the summer batch of 2021, the US-based early-stage accelerator programme Y Combinator selected ... |